2 Firms Take Advantage Of Deal-Happy Life Sciences Sector
The pair of legal advisers who guided Thursday's $1 billion purchase of Sprout Pharmaceuticals Inc. by Valeant Pharmaceuticals International Inc. have been capitalizing lately on a wildly active life sciences sector for deals,...To view the full article, register now.
Already a subscriber? Click here to view full article